Stryker Corporation (LON:0R2S)
London · Delayed Price · Currency is GBP · Price in USD | Market Cap | 103.69B |
| Revenue (ttm) | 18.14B |
| Net Income (ttm) | 2.19B |
| Shares Out | n/a |
| EPS (ttm) | 5.66 |
| PE Ratio | 47.36 |
| Forward PE | 24.42 |
| Dividend | 2.56 (0.72%) |
| Ex-Dividend Date | Sep 30, 2025 |
| Volume | 470 |
| Average Volume | 350 |
| Open | 366.77 |
| Previous Close | 372.00 |
| Day's Range | 356.42 - 369.29 |
| 52-Week Range | 327.13 - 406.70 |
| Beta | 0.99 |
| RSI | 37.81 |
| Earnings Date | Oct 30, 2025 |
About Stryker
Stryker Corporation operates as a medical technology company. It operates through two segments, MedSurg and Neurotechnology, and Orthopaedics. The MedSurg and Neurotechnology segment offers surgical equipment, and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, clinical communication and artificial intelligence-assisted virtual care platform technology, minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke,... [Read more]
Financial Performance
In 2024, Stryker's revenue was $22.60 billion, an increase of 10.23% compared to the previous year's $20.50 billion. Earnings were $2.99 billion, a decrease of -5.43%.
Financial numbers in USD Financial StatementsNews
Decoding Stryker Corp (SYK): A Strategic SWOT Insight
Decoding Stryker Corp (SYK): A Strategic SWOT Insight
Here's How Much $100 Invested In Stryker 10 Years Ago Would Be Worth Today
Stryker (NYSE: SYK) has outperformed the market over the past 10 years by 1.33% on an annualized basis producing an average annual return of 13.82%. Currently, Stryker has a market capitalization of ...
Compared to Estimates, Stryker (SYK) Q3 Earnings: A Look at Key Metrics
The headline numbers for Stryker (SYK) give insight into how the company performed in the quarter ended September 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estim...
Evercore ISI Maintains Outperform Rating on SYK, Lowers Price Target | SYK Stock News
Evercore ISI Maintains Outperform Rating on SYK, Lowers Price Target | SYK Stock News
SYK Stock Falls Despite Q3 Earnings & Sales Beat, '25 View Up
Stryker's Q3 results top estimates with double-digit sales and profit growth, but shares slip as investors weigh tariff pressures despite an upbeat 2025 outlook.
BTIG Maintains 'Buy' Rating for Stryker (SYK) and Raises Price Target | SYK Stock News
BTIG Maintains 'Buy' Rating for Stryker (SYK) and Raises Price Target | SYK Stock News
Stryker Corp (SYK) Q3 2025 Earnings Call Highlights: Strong Organic Growth and Strategic ...
Stryker Corp (SYK) Q3 2025 Earnings Call Highlights: Strong Organic Growth and Strategic Acquisitions Propel Performance
Q3 2025 Stryker Corp Earnings Call Transcript
Q3 2025 Stryker Corp Earnings Call Transcript
Stryker raises 2025 outlook to 9.8%-10.2% organic sales growth as momentum accelerates
Discover Stryker's Q3 2025 earnings call insights—organic growth, margin expansion, new acquisitions, and an upbeat outlook.
Stryker Corporation (SYK) Q3 2025 Earnings Call Transcript
Stryker raises lower end of annual profit forecast
Stryker on Thursday raised the lower end of its full-year profit forecast after beating estimates for third-quarter earnings, banking on strong demand for its medical and surgical devices.
Stryker Corp Q3 2025 Earnings: Revenue Surpasses Estimates at $6.1 Billion, EPS Falls Short at $2.22
Stryker Corp Q3 2025 Earnings: Revenue Surpasses Estimates at $6.1 Billion, EPS Falls Short at $2.22
SYK Forecasts Robust Organic Net Sales Growth by FY25
SYK Forecasts Robust Organic Net Sales Growth by FY25
SYK Q3 Revenue Surpasses Expectations with Strong Growth
SYK Q3 Revenue Surpasses Expectations with Strong Growth
Stryker down despite boosting 2025 outlook and Q3 beats
Stryker (SYK) Q3 Earnings and Revenues Beat Estimates
Stryker (SYK) delivered earnings and revenue surprises of +1.59% and +0.24%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Stryker Lifts Full-Year Sales View After Third-Quarter Revenue Rises
Stryker reports third quarter 2025 operating results
Portage, Michigan, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) reported operating results for the third quarter of 2025:
After-Hours Earnings Report for October 30, 2025 : AAPL, AMZN, GILD, SYK, COIN, MSTR, MSI, NET, AJG, RSG, MPWR, WDC
The following companies are expected to report earnings after hours on 10/30/2025. Visit our Earnings Calendar for a full list of expected earnings releases.Apple Inc. (AAPL)is reporting for the quart...
Stryker (SYK) Receives Overweight Rating and Raised Price Target from Barclays | SYK Stock News
Stryker (SYK) Receives Overweight Rating and Raised Price Target from Barclays | SYK Stock News
The Zacks Analyst Blog Highlights Moodys, Stryker and CBRE
Zacks highlights three wide-moat leaders Moody's, Stryker, and CBRE poised to deliver durable returns through strong fundamentals, innovation, and strategic expansion.
SYK Quantitative Stock Analysis
Below is Validea's guru fundamental report for STRYKER CORP (SYK). Of the 22 guru strategies we follow, SYK rates highest using our P/B Growth Investor model based on the published strategy of Partha ...
It's time to scoop up undervalued stocks in this critical sector of the economy
Expanding your horizons and considering neglected sectors can help you identify bargain opportunities while defending your investment portfolio from a stock-market decline.
Buy 3 Wide Moat Stocks to Enhance Your Portfolio Returns in Q4
MCO, SYK and CBRE stand out as wide moat stocks with strong growth forecasts and strategic expansions to boost portfolio resilience.
Stryker Breaks Above 200-Day Moving Average - Bullish for SYK
In trading on Monday, shares of Stryker Corp (Symbol: SYK) crossed above their 200 day moving average of $379.54, changing hands as high as $381.77 per share. Stryker Corp shares are currently trading...